Total Funding
30
23
Total FundingPost-IPO Secondary raised
Growth Score
2 pts
Heat Score
-42 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
117466
Werewolf Therapeutics operates as an oncology biotherapeutics company.
- Dan Hicklin: President and CEOPast Role: CoStim Pharmaceuticals, President and Chief Scientific Officer
Luke Evnin: Founder and ChairmanPast Role: Accel, General Partner
About the Company
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
